Safety and efficacy of polymer-free biolimus-eluting stents in all-comer patients: the RUDI-FREE study

EuroIntervention 2018;14:772-779 published online May 2018. DOI: 10.4244/EIJ-D-18-00148

Gennaro Sardella
Gennaro Sardella1*, MD; Giulio G. Stefanini2, MD, PhD; Carlo Briguori3, MD; Corrado Tamburino4, MD; Franco Fabbiocchi5, MD; Francesco Rotolo6, MD; Fabrizio Tomai7, MD; Anita Paggi8, MD; Mario Lombardi9, MD; Gaetano Gioffrè10, MD; Rocco Sclafani11, MD; Andrea Rolandi12, MD; Alessandro Sciahbasi13, MD; Francesco Scardaci14, MD; Nicola Signore15, MD; Simone Calcagno1, MD; Massimo Mancone1, MD, PhD; Mauro Chiarito2, MD; Arturo Giordano16
1. Department of Cardiovascular Sciences, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy; 2. Department of Biomedical Sciences, Humanitas University, Pieve Emanuele-Milan, Milan, Italy; 3. Clinica Mediterranea, Naples, Italy; 4. Ferrarott

Aims: Polymer-free biolimus-eluting stents (PF-BES) have been shown to be superior to bare metal stents in high bleeding risk (HBR) patients treated with one-month dual antiplatelet thera

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

acs/nste-acsbleedingclinical researchstable anginastemi
Coronary interventionsStents and scaffolds
Read next article
Establishment of healing profile and neointimal transformation in the new polymer-free biolimus A9-coated coronary stent by longitudinal sequential optical coherence tomography assessments: the EGO-BIOFREEDOM study

Latest news